Search

Medical services

The different clinical services constitute the backbone on which the healthcare activity of MD Anderson Cancer Center Madrid is organised.

COME BACK

Hematology


Hematology is the branch of medicine working on the study of the elements making up the blood and hematopoietic organs, in addition to structural and biochemical conditions of these elements which may lead to disease.

 

  • Hospitalization
  • Day Hospital
  • Outpatients
  • Emergency Care
  • Hospital Consultation
  • Laboratory
  • Blood Bank
  • Bone Marrow Transplant Unit

  • Anemia
  • Anemia in the elderly
  • Anemia in the cancer patient
  • Iron deficiency and iron deficiency anemia: low iron
  • Anemia associated with other chronic renal insufficiency, endocrinopathy and epatopathy type diseases.
  • Megaloblastic anemia due to a deficit of vitamin B12 or folic acid
  • Hemoglobinopathy and thalassemia
  • Congenital and acquired hemolytic anemia.
  • Sideroblastic anemia, diseritropoyesis
  • Erythrocytosis or polycythemia or increased concentration of RBCs

  • Neutropenia
  • Post chemotherapy neutropenia
  • Agranulocytosis
  • Neutrophilia
  • Acute Leukemias
  • Acute leukemia in the elderly
  • Acute myeloid leukemia
  • Secondary leukemia after chemotherapy
  • Acute promyelocytic leukemia
  • Myelodisplastic syndromes
  • Myelodisplasia in the elderly
  • Myeloproliferative syndromes
  • Chronic myeloid leukemia
  • Idiopathic or secondary myelofibrosis
  • Essential thrombocythemia
  • Polycythemia Vera
  • Idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia
  • Chronic neutrophilic leukemia
  • Mastocytosis

  • Lymphocytosis
  • Lymphopenia
  • Adenopathies
  • Splenomegaly or other disorders of the spleen
  • Neoplasms of the lymphatic system
  • Acute lymphoid leukemia in adults
  • Acute lymphoid leukemia in the elderly
  • Chronic lymphatic leukemia B-cell
  • Hairy cell leukemia
  • Splenic marginal zone lymphoma
  • Prolymphocytic leukemia
  • Large granular lymphocytic leukemia

  • Non-Hodgkin’s lymphoma
  • Follicular lymphoma
  • Lymphoma associated with the gastric mucosa, skin, eye, thyroid and breast and ther areas less commonly affected by lymphoma.
  • Mantle cell lymphoma
  • Large cell diffuse lymphoma
  • Primary mediastinal lymphoma
  • Primary cerebral lymphoma
  • Burkitt’s lymphoma
  • Large cell anaplastic lymphomas ALK+
  • Peripheral T-cell lymphoma
  • Anaplastic lymphoma
  • Nasal lymphoma
  • Cutaneous lymphoma. Fungoid mycosis. Sezary syndrome.
  • Lymphoma in immunosuppressed patients
  • Hodgkin’s lymphoma

  • MGUS
  • Multiple myeloma
  • Amyloidosis
  • Waldenstrom’s macroglobulinemia
  • POEMS syndrome

  • Hemorrhagic diathesis
  • Purpura
  • Primary immune thrombocytopenia (PIT)
  • Idiopathic thrombocytopenic purpura
  • Thrombotic thrombocytopenic purpura and uremic hemolytic syndrome
  • Thrombocytopathy
  • Thrombocytosis or high platelet levels
  • Amegakaryocytic thrombocytopenia

  • Antiphospholipid syndrome
  • Venous thromboembolic disease
  • Thrombosis in the cancer patient
  • Hematologic study of repeated miscarriages
  • Thrombophilia study
  • Thrombo Incode©

  • Histiocytosis
  • Primary immunodeficiencies
  • Congenital granulocyte disorders
  • Hemochromatosis
  • Study of ferritin/high iron levels
  • Genetic study of hemochromatosis
  • Secondary iron overload
  • Infection in hematologic patients
  • Medullary insufficiency
  • Acquired aplastic anemia
  • Paroxysmal nocturnal hemoglobinuria
  • Blackfan-Diamond anemia
  • Drug induced agranulocytosis

  • Bone marrow aspiration and bone marrow biopsy
  • Lumbar puncture and intrathecal chemotherapy
  • Plasmapheresis
  • Stem cell apheresis or progenitor stem cell transplant

  • Chemotherapy of hematologic neoplasia
  • Administration of monoclonal antibodies
  • Administration of molecular targeted anticancer drugs (tyrosine kinase inhibitors)
  • Conditioning regime for Hematopoietic Progenitor Cell Transplant
  • Hematopoietic Progenitor Cell Infusion
  • Plasmapheresis
  • Blood component transfusion
  • Intravenous immunoglobulin therapy
  • Intravenous iron therapy
  • Bleeding therapy

The access to drugs and new treatment options is of particular interest for patients for whom conventional treatment strategies have run out, but also for those who do not wish to undergo standard chemotherapy treatments. New molecules are being developed that act as treatment targets and are only accessible by participating in clinical trials. These treatments seem to minimize the systemic side effects of conventional chemotherapy. At MD Anderson Madrid Hematology service, we run several clinical trials for patients with hematologic disease.


We have units specially developed to apply a multidisciplinary approach. The aim of these units is to work in coordination with the different specialists at the hospital to study and fully treat our patients.

  • Hematopathology and benign hematologic disorders unit
  • Thrombosis and cancer unit
  • Lymphoma unit
  • Leukemia unit
  • Monoclonal gammapathy and multiple myeloma unit
  • Hematopoietic progenitor cell transplant unit

  • Hodgkin's Lymphoma
  • Leukemia
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Disorders
  • Non-Hodgkin's Lymphoma
  • Waldenström's Macroglobulinemia